Retrieve Medical Holdings Inc. Announces Letter of Intent to Acquire Cúratus LLC, Strengthening AI-Powered Healthcare Solutions
Rhea-AI Summary
Retrieve Medical Holdings has signed a Letter of Intent to acquire Cúratus , a Nevada-based technology company specializing in AI-driven provider data solutions. The acquisition will integrate Cúratus' SaaS platform, ProviderLenz, into Retrieve's healthcare solutions network.
The deal is subject to definitive agreement, closing conditions, public filings, and shareholder approval. Mark Fabiano, Cúratus' CEO and former Chief Sales Officer at Altegra Health, will continue leading the company as a subsidiary of Retrieve Medical Holdings.
ProviderLenz uses AI to aggregate and verify provider credentialing and directory data in real-time, addressing a critical issue in healthcare where credentialing errors and fraud contribute to over $100 billion in annual healthcare fraud costs. The merger aims to enhance operational efficiency, improve decision-making, and optimize patient care through advanced AI capabilities.
Positive
- Integration of ProviderLenz platform addresses $100B+ healthcare fraud market
- Acquisition of proven leadership with CEO having previous exit experience ($900M)
- Strategic expansion into AI-driven provider data solutions
- Potential for operational cost reduction through AI automation
Negative
- Transaction subject to multiple approval conditions and uncertainties
- Integration costs and risks not disclosed
- Financial terms of acquisition not disclosed
News Market Reaction 1 Alert
On the day this news was published, RMHI gained 56.90%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BEDMINSTER, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings Inc. (“Retrieve”), a Nevada corporation, today announced that it has signed a Letter of Intent (LOI) to acquire Cúratus LLC (“Curatus”), a Nevada-based technology company specializing in AI-driven provider data solutions. This strategic acquisition aims to enhance Retrieve’s portfolio by integrating Curatus’ innovative SaaS platform, ProviderLenz, into its growing network of healthcare solutions.
The transaction is contingent upon the finalization of a definitive agreement, the completion of customary closing conditions, including necessary public filings, and shareholder approval. This acquisition will combine the complementary strengths of both organizations, creating a more robust and forward-thinking entity positioned to drive growth and improve operational efficiency in the healthcare sector.
Following the acquisition, Mark Fabiano, CEO of Cúratus, is expected to continue leading the company as a wholly-owned subsidiary of Retrieve Medical Holdings. Prior to cofounding Cúratus, Mark served as Chief Sales Officer at Altegra Health, a provider of technology-enabled analytics services to that was grown to provide services nearly 200 regional and national payers before being acquired in 2015 for over
“We are thrilled to join forces with Retrieve Medical Holdings to revolutionize provider data management,” said Mark Fabiano, CEO of Cúratus. “This acquisition enables both companies to harness AI capabilities in innovative ways—driving operational efficiencies, improving decision-making, and ultimately optimizing patient care and satisfaction across the healthcare ecosystem.”
Curatus’ flagship platform, ProviderLenz, leverages AI to aggregate and verify provider credentialing and directory data in real-time, addressing the widespread issue of inaccurate provider data. Given that credentialing errors and fraud contribute to more than
The acquisition will empower both organizations to leverage advanced AI tools for automating routine tasks, enhancing data analysis, and creating tailored solutions that elevate customer experiences. With a shared commitment to AI, the combined entity will enable healthcare organizations to streamline their technology platforms, reduce administrative overhead, and gain a competitive advantage in an increasingly complex and rapidly changing industry.
About Retrieve Medical Holdings Inc.
Retrieve Medical Holdings, Inc. is transforming healthcare with its cutting-edge software platform, Retrieve Dx™. Using advanced natural language processing, Retrieve Dx™ analyzes patient data from multiple sources, helping physicians quickly understand complex clinical histories and diagnose chronic conditions. This technology integrates with leading electronic medical record systems such as Epic and Oracle Cerner, improving workflow, boosting patient outcomes, and increasing revenue for healthcare providers.
About Cúratus LLC
Founded in 2018 by Cory and Mark Fabiano and Jarrod Mandozzi, Cúratus is an innovative health IT company specializing in provider data management (PDM). Its AI-powered platform, ProviderLenz®, automates the distribution of accurate, up-to-date provider data across health plans and provider groups, improving efficiency, reducing costs, and enhancing compliance. In 2024, Cúratus was selected by one of the largest healthcare IT companies to integrate its PDM technology with leading healthcare claims platforms, enabling bi-directional, automated data exchange and further streamlining workflows across the healthcare ecosystem.
For more information, visit Retrieve Medical, Inc. at www.retrievemedical.com.
Contact info: Harriet Donnelly, CMO
Retrieve Medical, Inc.
908-392-3801
hdonnelly@retrievemedical.com
FAQ
What is the strategic importance of Retrieve Medical Holdings (RMHI) acquiring Cúratus?
When will the RMHI-Cúratus acquisition be completed?
What is the value of the Cúratus acquisition by RMHI?
How will ProviderLenz technology benefit RMHI's operations?
Who will lead Cúratus after the RMHI acquisition?
